Comparing analgesia and μ-opioid receptor internalization produced by intrathecal enkephalin: Requirement for peptidase inhibition

Neuropharmacology

Volumn 53, Issue 5, 2007, Pages 664-676

  Chen, Wenling ^a   Song, Bingbing ^a   Lao, Lijun ^a   Pérez, Orlando A ^a   Kim, Woojae ^a   Marvizón, Juan Carlos G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aminopeptidase; Delta opioid receptor; Dipeptidyl carboxypeptidase; Dorsal horn; EC.3.4.11.7; EC.3.4.15.1; EC.3.4.24.11; Endomorphin; Enkephalin; Intrathecal; Mu opioid receptor; Neutral endopeptidase; Peptidase inhibitors; Tail flick test

Indexed keywords

AMASTATIN; CAPTOPRIL; DELTA OPIATE RECEPTOR; ENDOMORPHIN 2; ENKEPHALIN; LEUCINE ENKEPHALIN; MU OPIATE RECEPTOR; OPIATE DERIVATIVE; PEPTIDASE; PHOSPHORAMIDON;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; ENZYME INHIBITION; INTERNALIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SPINAL CORD; TAIL FLICK TEST;

ANALGESIA; ANIMALS; DATA INTERPRETATION, STATISTICAL; ENKEPHALINS; IMMUNOHISTOCHEMISTRY; INJECTIONS, SPINAL; MALE; MICROSCOPY, CONFOCAL; OLIGOPEPTIDES; PAIN MEASUREMENT; PROTEASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU;

EID: 34948886579     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2007.07.010     Document Type: Article

References (73)

1. Abbadie C., Lombard M.C., Besson J.M., Trafton J.A., and Basbaum A.I. Mu and delta opioid receptor-like immunoreactivity in the cervical spinal cord of the rat after dorsal rhizotomy or neonatal capsaicin: an analysis of pre- and postsynaptic receptor distributions. Brain Research 930 (2002) 150-162
2. Abbadie C., Pasternak G.W., and Aicher S.A. Presynaptic localization of the carboxy-terminus epitopes of the mu opioid receptor splice variants MOR-1C and MOR-1D in the superficial laminae of the rat spinal cord. Neuroscience 106 (2001) 833-842
3. Aimone L.D., Jones S.L., and Gebhart G.F. Stimulation-produced descending inhibition from the periaqueductal gray and nucleus raphe magnus in the rat: mediation by spinal monoamines but not opioids. Pain 31 (1987) 123-136
4. Arvidsson U., Riedl M., Chakrabarti S., Lee J.H., Nakano A.H., Dado R.J., Loh H.H., Law P.Y., Wessendorf M.W., and Elde R. Distribution and targeting of a mu-opioid receptor MOR1 in brain and spinal cord. Journal of Neuroscience 15 (1995) 3328-3341
5. Bewley T.A., and Li C.H. Tertiary structure in deletion analogues of human beta-endorphin: resistance to leucine aminopeptidase action. Biochemistry 24 (1985) 6568-6571
6. Bourgoin S., Le Bars D., Clot A.M., Hamon M., and Cesselin F. Subcutaneous formalin induces a segmental release of Met-enkephalin-like material from the rat spinal cord. Pain 41 (1990) 323-329
7. Budai D., and Fields H.L. Endogenous opioid peptides acting at mu-opioid receptors in the dorsal horn contribute to midbrain modulation of spinal nociceptive neurons. Journal of Neurophysiology 79 (1998) 677-687
8. Cahill C.M., Morinville A., Lee M.C., Vincent J.P., Collier B., and Beaudet A. Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception. Journal of Neuroscience 21 (2001) 7598-7607
9. Cesselin F., Bourgoin S., Clot A.M., Hamon M., and Le Bars D. Segmental release of met-enkephalin-like material from the spinal-cord of rats, elicited by noxious thermal stimuli. Brain Research 484 (1989) 71-77
10. Chen S.R., and Pan H.L. Blocking mu opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids. Brain Research 1081 (2006) 119-125
11. Chen W., Song B., Lao L., Perez O.A., and Marvizon J.C. Intrathecal enkephalin requires inhibition of peptidases to produce analgesia and mu-opioid receptor internalization in dorsal horn neurons. Society for Neuroscience Abstracts 32 (2006) 643.18
12. Dawson-Basoa M., and Gintzler A.R. Involvement of spinal cord delta opiate receptors in the antinociception of gestation and its hormonal simulation. Brain Research 757 (1997) 37-42
13. Draisci G., Kajander K.C., Dubner R., Bennett G.J., and Iadarola M.J. Up-regulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammation. Brain Research 560 (1991) 186-192
14. Dyer S.H., Slaughter C.A., Orth K., Moomaw C.R., and Hersh L.B. Comparison of the soluble and membrane-bound forms of the puromycin-sensitive enkephalin-degrading aminopeptidases from rat. Journal of Neurochemistry 54 (1990) 547-554
15. Eckersell C.B., Popper P., and Micevych P.E. Estrogen-induced alteration of μ-opioid receptor immunoreactivity in the medial preoptic nucleus and medial amygdala. Journal of Neuroscience 18 (1998) 3967-3976
16. Gear R.W., Aley K.O., and Levine J.D. Pain-induced analgesia mediated by mesolimbic reward circuits. Journal of Neuroscience 19 (1999) 7175-7181
17. Gomes I., Jordan B.A., Gupta A., Trapaidze N., Nagy V., and Devi L.A. Heterodimerization of mu and delta opioid receptors: a role in opiate synergy. Journal of Neuroscience 20 (2000) RC110
18. Graf L., Miglecz E., Bajusz S., and Szekely J.I. Met-enkephalin attenuates morphine tolerance in rats. European Journal of Pharmacology 58 (1979) 345-346
19. Guyon A., Roques B.P., Guyon F., Foucault A., Perdrisot R., Swerts J.P., and Schwartz J.C. Enkephalin degradation in mouse brain studied by a new H.P.L.C. method: further evidence for the involvement of carboxydipeptidase. Life Sciences 25 (1979) 1605-1611
20. Han J.S. Acupuncture: neuropeptide release produced by electrical stimulation of different frequencies. Trends of Neuroscience 26 (2003) 17-22
21. Hiranuma T., Iwao K., Kitamura K., Matsumiya T., and Oka T. Almost complete protection from [Met5]-enkephalin-Arg6-Gly7-Leu8 (Met-enk-RGL) hydrolysis in membrane preparations by the combination of amastatin, captopril and phosphoramidon. Journal of Pharmacology and Experimental Therapeutics 281 (1997) 769-774
22. Hiranuma T., Kitamura K., Taniguchi T., Kanai M., Arai Y., Iwao K., and Oka T. Protection against dynorphin-(1-8) hydrolysis in membrane preparations by the combination of amastatin, captopril and phosphoramidon. Journal of Pharmacology and Experimental Therapeutics 286 (1998) 863-869
23. Hiranuma T., Kitamura K., Taniguchi T., Kobayashi T., Tamaki R., Kanai M., Akahori K., Iwao K., and Oka T. Effects of three peptidase inhibitors, amastatin, captopril and phosphoramidon, on the hydrolysis of [Met5]-enkephalin-Arg6-Phe7 and other opioid peptides. Naunyn-Schmiedebergs Archives of Pharmacology 357 (1998) 276-282
24. Honda M., Okutsu H., Matsuura T., Miyagi T., Yamamoto Y., Hazato T., and Ono H. Spinorphin, an endogenous inhibitor of enkephalin-degrading enzymes, potentiates Leu-enkephalin-induced anti-allodynic and antinociceptive effects in mice. Japanese Journal of Pharmacology 87 (2001) 261-267
25. Jensen T.S., and Yaksh T.L. Spinal monoamine and opiate systems partly mediate the antinociceptive effects produced by glutamate at brainstem sites. Brain Research 321 (1984) 287-297
26. Kazmierski W., Wire W.S., Lui G.K., Knapp R.J., Shook J.E., Burks T.F., Yamamura H.I., and Hruby V.J. Design and synthesis of somatostatin analogues with topographical properties that lead to highly potent and specific mu opioid receptor antagonists with greatly reduced binding at somatostatin receptors. Journal of Medicinal Chemistry 31 (1988) 2170-2177
27. Keith D.E., Anton B., Murray S.R., Zaki P.A., Chu P.C., Lissin D.V., Monteillet-Agius G., Stewart P.L., Evans C.J., and von Zastrow M. mu-Opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. Molecular Pharmacology 53 (1998) 377-384
28. Keith D.E., Murray S.R., Zaki P.A., Chu P.C., Lissin D.V., Kang L., Evans C.J., and von Zastrow M. Morphine activates opioid receptors without causing their rapid internalization. Journal of Biological Chemistry 271 (1996) 19021-19024
29. Kishioka S., Miyamoto Y., Fukunaga Y., Nishida S., and Yamamoto H. Effects of a mixture of peptidase inhibitors (amastatin, captopril and phosphoramidon) on Met-enkephalin-, beta-endorphin-, dynorphin-(1-13)- and electroacupuncture-induced antinociception in rats. Japanese Journal of Pharmacology 66 (1994) 337-345
30. Kitamura K., Akahori K., Yano H., Iwao K., and Oka T. Effects of peptidase inhibitors on anti-nociceptive action of dynorphin-(1-8) in rats. Naunyn-Schmiedebergs Archives of Pharmacology 361 (2000) 273-278
31. Kondo I., Marvizon J.C., Song B., Salgado F., Codeluppi S., Hua X.Y., and Yaksh T.L. Inhibition by spinal mu- and delta-opioid agonists of afferent-evoked substance P release. Journal of Neuroscience 25 (2005) 3651-3660
32. Kramer T.H., Shook J.E., Kazmierski W., Ayres E.A., Wire W.S., Hruby V.J., and Burks T.F. Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo. Journal of Pharmacology and Experimental Therapeutics 249 (1989) 544-551
33. Le Bars D., Bourgoin S., Clot A.M., Hamon M., and Cesselin F. Noxious mechanical stimuli increase the release of Met-enkephalin-like material heterosegmentally in the rat spinal cord. Brain Research 402 (1987) 188-192
34. Le Bars D., Bourgoin S., Villanueva L., Clot A.M., Hamon M., and Cesselin F. Involvement of the dorsolateral funiculi in the spinal release of met-enkephalin-like material triggered by heterosegmental noxious mechanical stimuli. Brain Research 412 (1987) 190-195
35. Lewis J.W., Sherman J.E., and Liebeskind J.C. Opioid and non-opioid stress analgesia: assessment of tolerance and cross-tolerance with morphine. Journal of Neuroscience 1 (1981) 358-363
36. LoPachin R.M., Rudy T.A., and Yaksh T.L. An improved method for chronic catheterization of the rat spinal subarachnoid space. Physiology and Behavior 27 (1981) 559-561
37. MacArthur L., Ren K., Pfaffenroth E., Franklin E., and Ruda M.A. Descending modulation of opioid-containing nociceptive neurons in rats with peripheral inflammation and hyperalgesia. Neuroscience 88 (1999) 499-506
38. Malmberg A.B., and Yaksh T.L. Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: effects of naltrindole and its benzofuran analog (NTB). Journal of Pharmacology and Experimental Therapeutics 263 (1992) 264-275
39. Martin-Schild S., Gerall A.A., Kastin A.J., and Zadina J.E. Endomorphin-2 is an endogenous opioid in primary sensory afferent fibers. Peptides 19 (1998) 1783-1789
40. Marvizon J.C., Grady E.F., Waszak-McGee J., and Mayer E.A. Internalization of μ-opioid receptors in rat spinal cord slices. Neuroreport 10 (1999) 2329-2334
41. Marvizon J.C.G., and Song B. Opioids are not co-released with neurokinins from primary afferent terminals in the rat dorsal horn. Society for Neuroscience Abstracts 28 (2002) 259.4
42. Marvizon J.C.G., Wang X., Lao L., and Song B. Effect of peptidases on the ability of exogenous and endogenous neurokinins to produce neurokinin 1 receptor internalization in the rat spinal cord. British Journal of Pharmacology 140 (2003) 1389-1398
43. McLamore S., Ullrich T., Rothman R.B., Xu H., Dersch C., Coop A., Davis P., Porreca F., Jacobson A.E., and Rice K.C. Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5alpha-epoxy-3,14-dihydroxy-6,7:2′, 3′-indolom orphinans, on opioid receptor affinity, selectivity, and efficacy. Journal Medical Chemistry 44 (2001) 1471-1474
44. Mills R.H., Sohn R.K., and Micevych P.E. Estrogen-induced μ-opioid receptor internalization in the medial preoptic nucleus is mediated via neuropeptide Y-Y1 receptor activation in the arcuate nucleus of female rats. Journal of Neuroscience 24 (2004) 947-955
45. Morgan M.M., Gold M.S., Liebeskind J.C., and Stein C. Periaqueductal gray stimulation produces a spinally mediated, opioid antinociception for the inflamed hindpaw of the rat. Brain Research 545 (1991) 17-23
46. Morinville A., Cahill C.M., Esdaile M.J., Aibak H., Collier B., Kieffer B.L., and Beaudet A. Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: evidence from mu-opioid receptor knock-out mice. Journal of Neuroscience 23 (2003) 4888-4898
47. Motulsky H., and Christopoulos A. Fitting Models to Biological Data Using Linear and Nonlinear Regression (2003), GraphPad Software, Inc., San Diego, CA
48. Nishimura K., and Hazato T. Isolation and identification of an endogenous inhibitor of enkephalin-degrading enzymes from bovine spinal cord. Biochemical Biophysical Research Communications 194 (1993) 713-719
49. Noble F., Turcaud S., Fournie-Zaluski M.C., and Roques B.P. Repeated systemic administration of the mixed inhibitor of enkephalin-degrading enzymes, RB101, does not induce either antinociceptive tolerance or cross-tolerance with morphine. European Journal of Pharmacology 223 (1992) 83-89
50. Nydahl K.S., Skinner K., Julius D., and Basbaum A.I. Co-localization of endomorphin-2 and substance P in primary afferent nociceptors and effects of injury: a light and electron microscopic study in the rat. European Journal of Neuroscience 19 (2004) 1789-1799
51. Paronis C.A., and Holtzman S.G. Increased analgesic potency of mu agonists after continuous naloxone infusion in rats. Journal of Pharmacology and Experimental Therapeutics 259 (1991) 582-589
52. Patierno S., Zellalem W., Ho A., Parsons C.G., Lloyd K.C., Tonini M., and Sternini C. N-methyl-d-aspartate receptors mediate endogenous opioid release in enteric neurons after abdominal surgery. Gastroenterology 128 (2005) 2009-2019
53. Pierce T.L., Grahek M.D., and Wessendorf M.W. Immunoreactivity for endomorphin-2 occurs in primary afferents in rats and monkey. Neuroreport 9 (1998) 385-389
54. Raynor K., Kong H., Chen Y., Yasuda K., Yu L., Bell G.I., and Reisine T. Pharmacological characterization of the cloned κ-, δ-, and μ-opioid receptors. Molecular Pharmacology 45 (1993) 330-334
55. Rougeot C., Messaoudi M., Hermitte V., Rigault A.G., Blisnick T., Dugave C., Desor D., and Rougeon F. Sialorphin, a natural inhibitor of rat membrane-bound neutral endopeptidase that displays analgesic activity. Proceedings of the National Academy of Sciences USA 100 (2003) 8549-8554
56. Sinchak K., and Micevych P.E. Progesterone blockade of estrogen activation of mu-opioid receptors regulates reproductive behavior. Journal of Neuroscience 21 (2001) 5723-5729
57. Song B., and Marvizon J.C. Peptidases prevent μ-opioid receptor internalization in dorsal horn neurons by endogenously released opioids. Journal of Neuroscience 23 (2003) 1847-1858
58. Song B., and Marvizon J.C.G. Dorsal horn neurons firing at high frequency, but not primary afferents, release opioid peptides that produce μ-opioid receptor internalization in the rat spinal cord. Journal of Neuroscience 23 (2003) 9171-9184
59. Song B., and Marvizon J.C.G. NMDA receptors and large conductance calcium-sensitive potassium channels inhibit the release of opioid peptides that induce μ-opioid receptor internalization in the rat spinal cord. Neuroscience 136 (2005) 549-562
60. Spike R.C., Puskar Z., Sakamoto H., Stewart W., Watt C., and Todd A.J. MOR-1-immunoreactive neurons in the dorsal horn of the rat spinal cord: evidence for nonsynaptic innervation by substance P-containing primary afferents and for selective activation by noxious thermal stimuli. European Journal of Neuroscience 15 (2002) 1306-1316
61. Takemori A.E., and Portoghese P.S. Enkephalin antinociception in mice is mediated by delta 1- and delta 2-opioid receptors in the brain and spinal cord, respectively. European Journal of Pharmacology 242 (1993) 145-150
62. Trafton J.A., Abbadie C., Marek K., and Basbaum A.I. Postsynaptic signaling via the mu-opioid receptor: responses of dorsal horn neurons to exogenous opioids and noxious stimulation. Journal of Neuroscience 20 (2000) 8578-8584
63. Tsou K., Khachaturian H., Akil H., and Watson S.J. Immunocytochemical localization of pro-opiomelanocortin-derived peptides in the adult rat spinal cord. Brain Research 378 (1986) 28-35
64. West W.L., Yeomans D.C., and Proudfit H.K. The function of noradrenergic neurons in mediating antinociception induced by electrical stimulation of the locus coeruleus in two different sources of Sprague-Dawley rats. Brain Research 626 (1993) 127-135
65. Whistler J.L., Chuang H.H., Chu P., Jan L.Y., and von Zastrow M. Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron 23 (1999) 737-746
66. Wisner A., Dufour E., Messaoudi M., Nejdi A., Marcel A., Ungeheuer M.N., and Rougeot C. Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathways. Proceedings of the National Academy of Sciences USA 13 (2006) 13
67. Yabaluri N., and Medzihradsky F. Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling. Molecular Pharmacology 52 (1997) 896-902
68. Yaksh T.L., and Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiology and Behavior 17 (1976) 1031-1036
69. Yaksh T.L., Terenius L., Nyberg F., Jhamandas K., and Wang J.Y. Studies on the release by somatic stimulation from rat and cat spinal cord of active materials which displace dihydromorphine in an opiate-binding assay. Brain Research 268 (1983) 119-128
70. Yamada K., and Nabeshima T. Stress-induced behavioral responses and multiple opioid systems in the brain. Behavioural Brain Research 67 (1995) 133-145
71. Zadina J.E., Hackler L., Ge L.J., and Kastin A.J. A potent and selective endogenous agonist for the μ-opiate receptor. Nature 386 (1997) 499-502
72. Zhou Q., Karlsson K., Liu Z., Johansson P., Le Greves M., Kiuru A., and Nyberg F. Substance P endopeptidase-like activity is altered in various regions of the rat central nervous system during morphine tolerance and withdrawal. Neuropharmacology 41 (2001) 246-253
73. Zorman G., Belcher G., Adams J.E., and Fields H.L. Lumbar intrathecal naloxone blocks analgesia produced by microstimulation of the ventromedial medulla in the rat. Brain Research 236 (1982) 77-84